Expression of EBV/C3d receptors on T cells: biological significance
- 28 February 1993
- journal article
- research article
- Published by Elsevier in Immunology Today
- Vol. 14 (2) , 56-59
- https://doi.org/10.1016/0167-5699(93)90059-t
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Interaction between Epstein‐Barr virus and a T cell line (HSB‐2) via a receptor phenotypically distinct from complement receptor type 2European Journal of Immunology, 1992
- Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2.The Journal of Experimental Medicine, 1991
- Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21)European Journal of Immunology, 1991
- The role of C3 in the immune responseImmunology Today, 1991
- Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.The Journal of Experimental Medicine, 1991
- Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA + T-cell lymphoma containing linear, EBV DNAClinical Immunology and Immunopathology, 1990
- Epstein--Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytesJournal of General Virology, 1990
- The multifunctional role of C3, the third component of complementImmunology Today, 1988
- T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus InfectionsNew England Journal of Medicine, 1988
- A human lymphoid cell line with receptors for both sheep red blood cells and complementCellular Immunology, 1974